Examining Factors Associated With Medication Adherence in Youth With Bipolar Disorder

Overview

Journal JAACAP Open

Date 2024 Oct 9

PMID 39381188

Authors

Mohamed Y Elhosary

John A Merranko

Tina R Goldstein

Danella M Hafeman

Benjamin I Goldstein

Mary Kay Gill

Heather Hower

David A Axelson

Jeffrey I Hunt

Shirley Yen

Rasim Somer Diler

Neal D Ryan

Martin B Keller

Lauren M Weinstock

Michael Strober

Boris Birmaher

Affiliations

Soon will be listed here.

Abstract

Objective: To assess medication adherence and factors associated with poor adherence in youth with bipolar disorder (BD) followed from adolescence through young adulthood.

Method: Participants with BD recruited through the Course and Outcome of Bipolar Youth (COBY) study were included in this study if they were prescribed psychotropic medications and had at least 3 follow-up assessments of medication adherence (N= 179, ages 12-36). Medication adherence had been evaluated for a median of 8 years using a questionnaire derived from the Coronary Artery Risk Development in Young Adults (CARDIA) study. For the longitudinal evaluation, adherence was measured as the percentage of follow-up assessments in which the participants did not endorse any of the nonadherence items included in the questionnaire. Concurrent and future predictors of poor adherence were assessed using both univariate and multivariate longitudinal analyses.

Results: Among the participants, 51% reported poor adherence in more than 50% of their follow-up assessments. Younger age, family conflicts, polypharmacy, lower functioning, greater severity of mood symptoms, and comorbid disorders were associated with poor adherence in the univariate analyses. In the multivariate analyses, comorbid ADHD was the single most influential factor associated with concurrent and future poor adherence in all age groups. Participants' most reported reasons for poor adherence were forgetfulness (56%), negative attitudes toward medication treatment (10.5%), and disturbed daily routine (7%).

Conclusions: Poor medication adherence is a significant problem in youth with BD with the most influential factor being the presence of comorbid ADHD. Thus, it is important to identify and appropriately treat comorbid ADHD to improve medication adherence and patients' prognosis. Providers should also recommend tools to enhance consistent medication intake and address patients' concerns and negative beliefs about their illness and treatment.

Citing Articles

Understanding Relapse in Bipolar Disorder at a Tertiary Mental Health Facility in Uganda.

Kimbowa P, Nalwoga V, Namwanje S, Ssekulima J, Anguparu S Neuropsychiatr Dis Treat. 2025; 21:395-408.

PMID: 40034127 PMC: 11874769. DOI: 10.2147/NDT.S495820.

Challenges and strategies for improving medication adherence among adolescent psychiatric patients: A qualitative study.

Kalaman C, Ibrahim N, Cham C, Ho M, Visvalingam U, Abdul Rahman F Glob Ment Health (Camb). 2025; 11():e117.

PMID: 39776998 PMC: 11704366. DOI: 10.1017/gmh.2024.80.

References

Baldessarini R, Tondo L, Vazquez G, Undurraga J, Bolzani L, Yildiz A . Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry. 2012; 11(1):40-6. PMC: 3266753. DOI: 10.1016/j.wpsyc.2012.01.006. View

Drotar D, Greenley R, Demeter C, McNamara N, Stansbrey R, Calabrese J . Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7):831-9. DOI: 10.1097/chi.0b013e31805c7421. View

Walker S, Mackay E, Barnett P, Rains L, Leverton M, Dalton-Locke C . Clinical and social factors associated with increased risk for involuntary psychiatric hospitalisation: a systematic review, meta-analysis, and narrative synthesis. Lancet Psychiatry. 2019; 6(12):1039-1053. PMC: 7029280. DOI: 10.1016/S2215-0366(19)30406-7. View

Birmaher B, Brent D, Chiappetta L, Bridge J, Monga S, Baugher M . Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999; 38(10):1230-6. DOI: 10.1097/00004583-199910000-00011. View

Birmaher B, Axelson D, Goldstein B, Strober M, Gill M, Hunt J . Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009; 166(7):795-804. PMC: 2828047. DOI: 10.1176/appi.ajp.2009.08101569. View

Corden M, Koucky E, Brenner C, Palac H, Soren A, Begale M . MedLink: A mobile intervention to improve medication adherence and processes of care for treatment of depression in general medicine. Digit Health. 2018; 2:2055207616663069. PMC: 6001228. DOI: 10.1177/2055207616663069. View

Salas M, Kiefe C, Schreiner P, Kim Y, Juarez L, Person S . Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study. Patient. 2012; 1(1):41-54. DOI: 10.2165/01312067-200801010-00007. View

Hafeman D, Rooks B, Merranko J, Liao F, Gill M, Goldstein T . Lithium Versus Other Mood-Stabilizing Medications in a Longitudinal Study of Youth Diagnosed With Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2019; 59(10):1146-1155. PMC: 6987013. DOI: 10.1016/j.jaac.2019.06.013. View

Lavsa S, Holzworth A, Ansani N . Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011; 51(1):90-4. DOI: 10.1331/JAPhA.2011.09154. View

10.

Oates G, Juarez L, Hansen B, Kiefe C, Shikany J . Social Risk Factors for Medication Nonadherence: Findings from the CARDIA Study. Am J Health Behav. 2020; 44(2):232-243. PMC: 7370319. DOI: 10.5993/AJHB.44.2.10. View

11.

Morisky D, Green L, Levine D . Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. DOI: 10.1097/00005650-198601000-00007. View

12.

He H, Hu C, Ren Z, Bai L, Gao F, Lyu J . Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017. J Psychiatr Res. 2020; 125:96-105. DOI: 10.1016/j.jpsychires.2020.03.015. View

13.

Hack S, Chow B . Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol. 2001; 11(1):59-67. DOI: 10.1089/104454601750143465. View

14.

Sanchez M, Lytle S, Neudecker M, McVoy M . Medication Adherence in Pediatric Patients with Bipolar Disorder: A Systematic Review. J Child Adolesc Psychopharmacol. 2021; 31(2):86-94. DOI: 10.1089/cap.2020.0098. View

15.

Lawson K, Johnsrud M, Hodgkins P, Sasane R, Crismon M . Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther. 2012; 34(4):944-956.e4. DOI: 10.1016/j.clinthera.2012.02.021. View

16.

Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P . Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997; 36(7):980-8. DOI: 10.1097/00004583-199707000-00021. View

17.

Keller M, Lavori P, Friedman B, Nielsen E, Endicott J, Andreasen N . The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987; 44(6):540-8. DOI: 10.1001/archpsyc.1987.01800180050009. View

18.

Brown C, Battista D, Bruehlman R, Sereika S, Thase M, Dunbar-Jacob J . Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care. 2005; 43(12):1203-7. DOI: 10.1097/01.mlr.0000185733.30697.f6. View

19.

DiMatteo M, Giordani P, Lepper H, Croghan T . Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002; 40(9):794-811. DOI: 10.1097/00005650-200209000-00009. View

20.

Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R . Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework. J Affect Disord. 2008; 116(1-2):51-5. DOI: 10.1016/j.jad.2008.11.004. View